CompletedPhase 2NCT00352365

Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia

Studying Acute basophilic leukemia

Last synced from ClinicalTrials.gov May 6, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: National Cancer Institute (NCI)
Principal Investigator: Mikkael Sekeres, MD
SWOG Cancer Research Network
Intervention: lenalidomide(drug)
Enrollment: 41 enrolled
Eligibility: 60 years · All sexes
Timeline: 2006 – 2011

Study locations (30)

University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
Shasta Regional Medical Center, Redding, California, United States
Sutter Roseville Medical Center, Roseville, California, United States
Sutter General Hospital, Sacramento, California, United States
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Cancer Care Center of Decatur, Decatur, Illinois, United States
Decatur Memorial Hospital, Decatur, Illinois, United States
Memorial Medical Center, Springfield, Illinois, United States
Salina Regional Health Center, Salina, Kansas, United States
University of Michigan, Ann Arbor, Michigan, United States
Montana Cancer Consortium CCOP, Billings, Montana, United States
Northern Rockies Radiation Oncology Center, Billings, Montana, United States
Saint Vincent Healthcare, Billings, Montana, United States
Hematology-Oncology Centers of the Northern Rockies PC, Billings, Montana, United States
Billings Clinic, Billings, Montana, United States
+15 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00352365 on ClinicalTrials.gov

Other trials for Acute basophilic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute basophilic leukemia →

← Back to all trials